test

Ilko Menkov

@Vestal Point Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$1.319BTotal holdings69
Assets growth rate-1.67%Assets growth rate (2-Q avg)4.62%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Vestal Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Vestal Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.319B in assets, with a quarterly growth rate of -1.67% and a 2-quarter average growth rate of 4.62%. The portfolio is managed by Ilko Menkov, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
JAZZJazz Pharmaceuticals Plc
Recent Activity
Decreased -40%
7.61%
$100.269M
900,000 shares@ $111.41 avg price
CYTKCytokinetics Inc
Recent Activity
Decreased -27.71%
6.01%
$79.2M
1.5M shares@ $52.8 avg price
RAREUltragenyx Pharmaceutical Inc
Recent Activity
Decreased -58.33%
3.16%
$41.663M
750,000 shares@ $55.55 avg price
ASNDAscendis Pharma A S
Recent Activity
Decreased -66.66%
2.84%
$37.328M
250,000 shares@ $149.31 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
Decreased -40%
2.76%
$36.353M
720,000 shares@ $50.49 avg price
JANXJanux Therapeutics Inc
Recent Activity
Decreased -33.1%
1.68%
$22.034M
485,000 shares@ $45.43 avg price
LQDALiquidia Corp
Recent Activity
Decreased -18.03%
1.14%
$15M
1.5M shares@ $10.0 avg price
BMYBristol-myers Squibb Co
Recent Activity
Decreased -50%
0.99%
$12.935M
250,000 shares@ $51.74 avg price
DNTHDianthus Therapeutics Inc
Recent Activity
Decreased -34.16%
0.83%
$10.815M
395,000 shares@ $27.38 avg price
ITOSIteos Therapeutics Inc
Recent Activity
Decreased -41.42%
0.8%
$10.465M
1.025M shares@ $10.21 avg price